发明名称 Microorganism for genetic therapeutic treatment of proliferative diseases
摘要 Disclosed is a bacterium in whose genome the following components are inserted and can be expressed: I) a nucleotide sequence that encodes a directly or indirectly, antiproliferatively or cytotoxically active expression product or a plurality of said expression products, II) a nucleotide sequence that encodes for a blood plasma protein under the control of an activation sequence that can be activated in the bacterium, or that is constitutively active, III) optionally, a nucleotide sequence that encodes for a cell-specific ligand under the control of an activation sequence that can be activated in the bacterium, or is constitutively active, IV) a nucleotide sequence for a transport system that induces expression of the expression products of components I) and II) and optionally III) on the outer surface of the bacterium or that induces secretion of the expression products of component I) and expression of component II) and optionally III) and that is optionally constitutively active, V) optionally a nucleotide sequence for a protein for lysis of the bacterium in the cytosol of mammalian cells and for the intracellular release of plasmids contained in the lysed bacterium, and VI) an activation sequence that can be activated in the bacterium, and/or that is tissue cell-specific, tumor cell-specific, function-specific or not cell-specific, for expressing component I), wherein any of components I) to VI) is present either once or several times, and either identical or different.
申请公布号 NZ535310(A) 申请公布日期 2008.04.30
申请号 NZ20030535310 申请日期 2003.02.13
申请人 ZENTARIS GMBH 发明人 GOEBEL, WERNER;RAPP, R ULF;SEDLACEK, HANS-HARALD;FENSTERLE, JOACHIM;GENTSCHEV, IVAYLO
分类号 C12N15/09;A61K35/74;A61K35/76;A61K39/00;A61K48/00;A61P29/00;A61P35/00;A61P35/02;A61P37/02;A61P37/06;C07K14/705;C07K14/765;C12N1/00;C12N1/21;C12N7/04;C12N9/24;C12N15/63;C12N15/74;(IPC1-7):C12N15/85 主分类号 C12N15/09
代理机构 代理人
主权项
地址
您可能感兴趣的专利